Through the 90-day period concluding December 12, 2025, Artiva Biotherapeutics's top three insider stakeholders include President And CEO Fred Aslan (344.00K shares), COO And Clo And Secy And Compliance Off Jennifer Bush (148.05K shares), Chief Financial Officer Neha Krishnamohan (99.36K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Corp. Gc | 4,567,412 | 22 Jul, 2024 | |
| Global Strategic Fund Iii, L.P. Venbio | 1,936,637 | 22 Jul, 2024 | |
| Yong-Jun Huh | 1,260,512 | 22 Jul, 2024 | |
| Fred Aslan | President And CEO | 1,213,135 | 12 Dec, 2025 |
| Partners Vi, Llc 5Am | 1,182,054 | 24 Jul, 2024 | |
| Capital Management, L.P. Ra | 826,832 | 24 Jul, 2024 | |
| Jennifer Bush | COO And Clo And Secy And Compliance Off | 232,925 | 12 Dec, 2025 |
| Biomedical Innovation Master Investors (Cayman) I L.P. Wellington | 194,108 | 22 Jul, 2024 | |
| Christopher Horan | Chief Tech Operations Officer | 185,339 | 12 Dec, 2025 |
| Heather Raymon | SVP And Research And Development | 106,844 | 12 Dec, 2025 |
| Neha Krishnamohan | Chief Financial Officer | 99,356 | 17 Nov, 2025 |
| Thorsten Graef | Chief Medical Officer | 80,000 | 28 Feb, 2025 |
| Subhashis Banerjee | Chief Medical Officer | 50,000 | 25 Apr, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 12 Dec, 2025 | Christopher Horan | Common Stock | A | 107,156 | $0.00 | 185,339 | D | A |
| 12 Dec, 2025 | Jennifer Bush | Common Stock | A | 84,877 | $0.00 | 232,925 | D | A |
| 12 Dec, 2025 | Heather Raymon | Common Stock | A | 67,253 | $0.00 | 106,844 | D | A |
| 12 Dec, 2025 | Fred Aslan | Common Stock | A | 869,136 | $0.00 | 1,213,135 | D | A |
| 15 Nov, 2025 | Jennifer Bush | Common Stock | D | 3,055 | $3.25 | 148,048 | D | F |
| 15 Nov, 2025 | Neha Krishnamohan | Common Stock | D | 3,490 | $3.25 | 99,356 | D | F |
| 15 Nov, 2025 | Fred Aslan | Common Stock | D | 6,347 | $3.25 | 350,374 | D | F |
| 15 Nov, 2025 | Christopher Horan | Common Stock | D | 1,899 | $3.25 | 78,183 | D | F |
| 15 Nov, 2025 | Heather Raymon | Common Stock | D | 1,375 | $3.25 | 39,591 | D | F |
| 17 Nov, 2025 | Fred Aslan | Common Stock | D | 6,375 | $3.38 | 343,999 | D | S |
| 17 Oct, 2025 | Fred Aslan | Common Stock | D | 25,500 | $6.00 | 356,721 | D | S |
| 08 Apr, 2025 | Subhashis Banerjee | Common Stock | A | 50,000 | $0.00 | 50,000 | D | A |
| 08 Apr, 2025 | Subhashis Banerjee | - | - | 50,000 | D | |||
| 05 Mar, 2025 | Fred Aslan | Common Stock | A | 200,000 | $0.00 | 416,665 | D | A |
| 26 Feb, 2025 | Thorsten Graef | - | - | 80,000 | D | |||
| 26 Feb, 2025 | Christopher Horan | Common Stock | A | 60,000 | $0.00 | 85,000 | D | A |
| 26 Feb, 2025 | Thorsten Graef | Common Stock | A | 60,000 | $0.00 | 80,000 | D | A |
| 26 Feb, 2025 | Jennifer Bush | Common Stock | A | 86,650 | $0.00 | 159,449 | D | A |
| 26 Feb, 2025 | Neha Krishnamohan | Common Stock | A | 60,000 | $0.00 | 110,000 | D | A |
| 26 Feb, 2025 | Heather Raymon | Common Stock | A | 33,350 | $0.00 | 43,350 | D | A |